Published in J Clin Invest on June 01, 1992
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest (1994) 2.51
The effect of non-insulin-dependent diabetes mellitus and obesity on glucose transport and phosphorylation in skeletal muscle. J Clin Invest (1996) 1.56
Myocardial and skeletal muscle glucose uptake during exercise in humans. J Physiol (2002) 1.50
Mechanisms modifying glucose oxidation in diabetes mellitus. Diabetologia (1994) 1.22
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest (1993) 1.22
¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging (2011) 1.15
Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J Clin Invest (1996) 1.10
Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest (1996) 1.07
A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle. BMC Syst Biol (2011) 1.04
Depot-specific regulation of glucose uptake and insulin sensitivity in HIV-lipodystrophy. Am J Physiol Endocrinol Metab (2005) 1.01
Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest (1998) 1.00
Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance. J Clin Invest (1993) 1.00
Insulin action on heart and skeletal muscle glucose uptake in essential hypertension. J Clin Invest (1995) 0.92
Intact insulin stimulation of skeletal muscle blood flow, its heterogeneity and redistribution, but not of glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Invest (1997) 0.92
Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity. Aging Dis (2016) 0.88
Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle. J Clin Invest (1994) 0.87
Mangiferin stimulates carbohydrate oxidation and protects against metabolic disorders induced by high-fat diets. Diabetes (2014) 0.82
Obesity preserves myocardial function during blockade of the glycolytic pathway. Arq Bras Cardiol (2014) 0.81
Antilipolytic drug boosts glucose metabolism in prostate cancer. Nucl Med Biol (2013) 0.80
Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake. J Physiol (1999) 0.78
F-18 fluorodeoxyglucose uptake and water-perfusable tissue fraction in assessment of myocardial viability. Ann Nucl Med (2012) 0.77
Chronic aerobic exercise associated to dietary modification improve endothelial function and eNOS expression in high fat fed hamsters. PLoS One (2014) 0.77
Myocardial glucose uptake in patients with the m.3243A > G mutation in mitochondrial DNA. J Inherit Metab Dis (2015) 0.77
Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study. Br J Cancer (1999) 0.77
Obesity-associated intestinal insulin resistance is ameliorated after bariatric surgery. Diabetologia (2015) 0.77
Glucose transport and glucose transporter GLUT4 are regulated by product(s) of intermediary metabolism in cardiomyocytes. Biochem J (1997) 0.76
Influence of free fatty acids on glucose uptake in prostate cancer cells. Nucl Med Biol (2013) 0.76
Multi-Target Analysis and Design of Mitochondrial Metabolism. PLoS One (2015) 0.76
Femoral Bone Marrow Insulin Sensitivity Is Increased by Resistance Training in Elderly Female Offspring of Overweight and Obese Mothers. PLoS One (2016) 0.75
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet (1963) 16.71
The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem (1977) 11.55
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation (1977) 9.70
The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes (1981) 7.28
Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy. N Engl J Med (1990) 7.13
Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab (1985) 5.99
Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol (1979) 5.83
Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med (1986) 4.69
Effect of fatty acids on glucose production and utilization in man. J Clin Invest (1983) 4.00
Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes (1988) 3.67
On the production and utilisation of glycogen in normal and diabetic animals. J Physiol (1913) 3.33
A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res (1983) 3.15
Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol (1980) 3.12
Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest (1989) 3.03
Determination of free and total insulin and C-peptide in insulin-treated diabetics. Diabetes (1977) 2.79
A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J (1985) 2.77
Kinetics of glucose disposal in whole body and across the forearm in man. J Clin Invest (1987) 1.83
Effect of long chain triglyceride infusion on glucose metabolism in man. Metabolism (1982) 1.79
Inhibition of glucose uptake and glycogenolysis by availability of oleate in well-oxygenated perfused skeletal muscle. Biochem J (1977) 1.61
Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids. Diabetes (1974) 1.61
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47
Operation of Randle's cycle in patients with NIDDM. Diabetes (1990) 1.40
Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med (1989) 1.30
Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest (1985) 1.26
Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab (1991) 1.24
Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol (1991) 1.20
Time dependence of the interaction between lipid and glucose in humans. Am J Physiol (1989) 1.19
Interrelation of carbohydrate and palmitate metabolism in skeletal muscle. Am J Physiol (1971) 1.16
Effect of insulin on in vivo glucose utilization in individual tissues of anesthetized lactating rats. Am J Physiol (1987) 1.04
Effects of nonesterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest (1988) 1.02
Overnutrition induced decrease in insulin action for glucose storage: in vivo and in vitro in man. Metabolism (1986) 1.02
Effects of fatty acids on carbohydrate and fatty acid metabolism of rat diaphragm. Am J Physiol (1968) 1.01
Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med (1982) 1.00
Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia (1988) 1.00
Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol (1984) 0.98
Regulation of plasma lactate concentration in resting human subjects. Metabolism (1990) 0.95
Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diabet Med (1988) 0.92
Effect of octanoate on carbohydrate metabolism in red and white muscle of the rhesus monkey. Am J Physiol (1969) 0.90
Hormonal control of glycogen in the heart and other tissues in rats. Endocrinology (1956) 0.88
Increased uptake and phosphorylation of 2-deoxyglucose by skeletal muscles in endotoxin-treated rats. Am J Physiol (1987) 0.87
Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. Am J Physiol (1987) 0.87
Rabbit hindlimb glucose uptake assessed with positron-emitting fluorodeoxyglucose. J Appl Physiol (1985) (1989) 0.82
The measurement of metabolite exchange across muscle beds. Baillieres Clin Endocrinol Metab (1987) 0.82
Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data. J Nucl Med (1989) 0.81
EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging (2005) 3.61
Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res (2000) 2.84
Utilization of photon orbital angular momentum in the low-frequency radio domain. Phys Rev Lett (2007) 2.72
Influence of the blood glucose concentration on FDG uptake in cancer--a PET study. J Nucl Med (1993) 2.66
Apoptosis in human acute myocardial infarction. Circulation (1997) 2.45
Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography. J Nucl Med (1992) 2.40
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest (1999) 2.06
Epidemiological classification of acute myocardial infarction: time for a change? Eur Heart J (1999) 2.04
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum (1982) 1.83
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. J Nucl Med (2001) 1.81
Do postcard reminders improve influenza compliance? A prospective trial of different postcard "cues". Med Care (1982) 1.64
Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol (2001) 1.60
Protein C substitution in sepsis-associated purpura fulminans. Crit Care Med (2000) 1.60
Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med (1997) 1.58
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem (1998) 1.54
Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation (2010) 1.53
Physiological importance of dehydroepiandrosterone. Lancet (1994) 1.49
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47
Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins. Am J Clin Nutr (1992) 1.40
Effects of cocaine and related drugs in nonhuman primates. I. [3H]cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther (1989) 1.40
Massive baclofen overdose. Crit Care Resusc (2000) 1.40
Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia (1999) 1.40
The regulatory background of nuclear cardiology in Europe: a survey by the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging (2006) 1.39
Sex differences in striatal presynaptic dopamine synthesis capacity in healthy subjects. Biol Psychiatry (2002) 1.37
Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients. Lancet (1995) 1.37
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain (2001) 1.37
Cognitive impairment and the brain dopaminergic system in Parkinson disease: [18F]fluorodopa positron emission tomographic study. Arch Neurol (2000) 1.36
2 new groups of selective stimulants of adrenergic beta-receptors. Experientia (1969) 1.36
Bayesian image reconstruction for emission tomography based on median root prior. Eur J Nucl Med (1997) 1.34
Fluorine-18-labeled fluorine gas for synthesis of tracer molecules. Nucl Med Biol (1997) 1.34
PET amyloid ligand [11C]PIB uptake shows predominantly striatal increase in variant Alzheimer's disease. Brain (2008) 1.34
Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med (1979) 1.33
Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes (1995) 1.30
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes (1997) 1.30
Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) (1994) 1.29
Performance of the new generation of whole-body PET/CT scanners: Discovery STE and Discovery VCT. Eur J Nucl Med Mol Imaging (2007) 1.28
Structure elucidation of two tryptophan-derived, high affinity Ah receptor ligands. Chem Biol (1995) 1.28
Glucose uptake in the chronically dysfunctional but viable myocardium. Circulation (1996) 1.27
Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med (1978) 1.27
Enhanced oxygen extraction and reduced flow heterogeneity in exercising muscle in endurance-trained men. Am J Physiol Endocrinol Metab (2001) 1.26
Effects of dopamine D(1-like) and D(2-like) agonists in rats that self-administer cocaine. J Pharmacol Exp Ther (1999) 1.25
Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab (1991) 1.24
Kinetic modeling of [(18)F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab (2001) 1.22
Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation (1997) 1.22
Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex. Brain (2001) 1.22
Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest (1993) 1.22
Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab (1988) 1.22
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome. Neurology (2000) 1.22
Paraoxonase gene polymorphisms and coronary reactivity in young healthy men. J Mol Med (Berl) (2001) 1.21
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia. Schizophr Res (1999) 1.20
Coronary flow reserve: measurement with transthoracic Doppler echocardiography is reproducible and comparable with positron emission tomography. Clin Physiol (2001) 1.20
Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med (1997) 1.19
Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol (1998) 1.19
Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs. J Pharmacol Exp Ther (1998) 1.19
Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther (2000) 1.17
Muscle blood flow and flow heterogeneity during exercise studied with positron emission tomography in humans. Eur J Appl Physiol (2000) 1.16
Mechanisms of hyperglycemia-induced insulin resistance in whole body and skeletal muscle of type I diabetic patients. Diabetes (1992) 1.15
Regional cerebral oxidative and total glucose consumption during rest and activation studied with positron emission tomography. Acta Physiol Scand (1994) 1.13
Coronary flow reserve is reduced in young men with IDDM. Diabetes (1998) 1.13
Iodine- and chlorine-containing oxidation agents as hydroxylating catalysts in cytochrome P-450-dependent fatty acid hydroxylation reactions in rat liver microsomes. FEBS Lett (1976) 1.13
Rate of progression in Parkinson's disease: a 6-[18F]fluoro-L-dopa PET study. Mov Disord (2001) 1.13
Interactions of indoles with specific binding sites for 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Mol Pharmacol (1985) 1.12
Decrease in human striatal dopamine D2 receptor density with age: a PET study with [11C]raclopride. J Cereb Blood Flow Metab (1993) 1.11
Exercise and the metabolic syndrome. Diabetologia (1997) 1.11